TriSalus Life Sciences Inc
NASDAQ:TLSI
Relative Value
The Relative Value of one TLSI stock under the Base Case scenario is 4.61 USD. Compared to the current market price of 10.24 USD, TriSalus Life Sciences Inc is Overvalued by 55%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
TLSI Competitors Multiples
TriSalus Life Sciences Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
T
|
TriSalus Life Sciences Inc
NASDAQ:TLSI
|
308.2m USD | 16.6 | -4.9 | -5.5 | -5.5 | |
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
517.8B CAD | 0 | -143 509.4 | -798 104.5 | -798 104.5 | |
US |
V
|
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
|
332.4B USD | 0 | -692 592.7 | -140 273.7 | -140 273.7 | |
US |
G
|
Gould Investors LP
OTC:GDVTZ
|
304.4B USD | 0 | 0 | 0 | 0 | |
US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | 263 524.8 | -70 424.1 | -77 926.9 | -77 525.1 | |
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
76.3B Zac | 0 | 0 | 0 | 0 | |
US |
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | 0 | 0 | 0 | ||
US |
Ergo Science Corp
OTC:ERGN
|
55.2B USD | 2 160.3 | -12 841.6 | -10 816.3 | -10 391 | ||
US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | 0 | -33 104.9 | -34 818.3 | -34 818.3 | |
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
710.7T IDR | 15.6 | 40.5 | 29 | 29 | ||
US |
M
|
Myson Group Inc
OTC:MYSN
|
38.4B USD | 0 | 0 | 0 | 0 |